BSE
BSE stock data is delayed by 5 minutes.
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Zydus Lifesciences Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
532321
ISIN Demat
INE010B01027
Book Value (Rs)
237.3008466
NSE Symbol
ZYDUSLIFE
Divident Yield %
0.08
Market Cap
(Rs In Cr.)
124,089
P/E (TTM)
34.04
EPS (TTM)
36.54
Face Value
(Rs)
1
Back
Zydus' New Jersey office concludes USFDA inspection
28-Sep-26   Hrs IST

Zydus Lifesciences announced that the USFDA conducted onsite inspection of pharmacovigilance and post marketing surveillance system at the company's office based in New Jersey, USA. The inspection was conducted from 22 September to 25 September 2026. The inspection closed with NIL observations.

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed , Maintained and Content Powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)